PHARMACOKINETICS.

被引：0
|
作者：
Wingard Jr., L.B. [1 ]
机构：
[1] Univ of Pittsburgh, Pittsburgh, PA,, USA, Univ of Pittsburgh, Pittsburgh, PA, USA
来源：
| 1985年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
11
引用
收藏
页码：5 / 15
相关论文
共 50 条
  • [21] PHARMACOMETABOLOMICS DOES NOT EXPLAIN VARIABILITY IN PACLITAXEL PHARMACOKINETICS.
    Chen, L.
    Chen, C.
    Hertz, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S19 - S19
  • [22] COMPREHENSIVE PHARMACOGENETIC ANALYSIS OF IRINOTECAN NEUTROPENIA AND PHARMACOKINETICS.
    Innocenti, F.
    Kroetz, D. L.
    Schuetz, E.
    Dolan, E.
    Ramirez, J.
    Relling, M.
    Chen, P.
    Das, S.
    Rosner, G. L.
    Ratain, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S8 - S8
  • [23] Variable approaches for protecting antisense drugs and their pharmacokinetics.
    Cohen, AS
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S259 - S259
  • [24] Compartmental modeling in clinical pharmacokinetics. A technical review
    O'Grady, K.F.
    Doyle, D.J.
    Journal of Clinical Engineering, 1995, 20 (02):
  • [25] The effect of food and bedtime administration on duloxetine pharmacokinetics.
    Skinner, MH
    Skerjanec, A
    Seger, M
    Hewitt, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 129 - 129
  • [26] Influence of age and gender on pramipexole (PX) pharmacokinetics.
    Wright, CE
    Sisson, TL
    Ichhpurani, AK
    Peters, GR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI100 - PI100
  • [27] Time of dosing and food effects on aripiprazole pharmacokinetics.
    Ammerman, D
    Mallikaarjun, S
    Salazar, D
    Bramer, SL
    Xie, J
    Weston, IE
    PHARMACOTHERAPY, 2003, 23 (10): : 1362 - 1362
  • [28] SITE OF INJECTION DOES NOT AFFECT DULAGLUTIDE PHARMACOKINETICS.
    Moser, B. A.
    Cui, X.
    Loghin, C.
    Chaudhary, A.
    de la Pena, A.
    Chien, J. Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S73 - S73
  • [29] The effects of delayed graft function on mycophenolate mofetil pharmacokinetics.
    van Gelder, Teun
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 162 - 162
  • [30] EFFECT OF RENAL IMPAIRMENT ON DS-1040 PHARMACOKINETICS.
    Limsakun, T.
    Kobayashi, F.
    Pav, J.
    Vashi, V.
    Wyatt, D.
    Preston, R. A.
    Zhou, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S36 - S36
12345